Cargando…
4-Methylumbelliferone Targets Revealed by Public Data Analysis and Liver Transcriptome Sequencing
4-methylumbelliferone (4MU) is a well-known hyaluronic acid synthesis inhibitor and an approved drug for the treatment of cholestasis. In animal models, 4MU decreases inflammation, reduces fibrosis, and lowers body weight, serum cholesterol, and insulin resistance. It also inhibits tumor progression...
Autores principales: | Tsitrina, Alexandra A., Halimani, Noreen, Andreichenko, Irina N., Sabirov, Marat, Nesterchuk, Mikhail, Dashenkova, Nataliya O., Romanov, Roman, Bulgakova, Elena V., Mikaelyan, Arsen, Kotelevtsev, Yuri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917189/ https://www.ncbi.nlm.nih.gov/pubmed/36768453 http://dx.doi.org/10.3390/ijms24032129 |
Ejemplares similares
-
Phenotypic Alteration of BMDM In Vitro Using Small Interfering RNA
por: Halimani, Noreen, et al.
Publicado: (2022) -
4-methylumbelliferone Prevents Liver Fibrosis by Affecting Hyaluronan Deposition, FSTL1 Expression and Cell Localization
por: Andreichenko, Irina N., et al.
Publicado: (2019) -
Inhibition of hyaluronan secretion by novel coumarin compounds and chitin synthesis inhibitors
por: Tsitrina, Alexandra A, et al.
Publicado: (2021) -
Antioxidant Activities of 4-Methylumbelliferone Derivatives
por: Al-Majedy, Yasameen K., et al.
Publicado: (2016) -
Antitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancer
por: Yoshida, Eri, et al.
Publicado: (2016)